A Study of DLX105-DMP in Subjects With Plaque Psoriasis
Status:
Not yet recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
A Pilot, Open-Label Study in Subjects with Mild-to-Moderate Plaque Psoriasis to Investigate
the Safety, Tolerability, and Preliminary Efficacy of a Four-Week Multidose Regimen of
DLX105-DMP Administered to a Target Lesion